The selective ERβ agonist DPN decreased melanoma cell proliferation at a concentration of 10−8 M, while the selective ERα agonist PPT had no effect on melanoma cell proliferation at 10−8 M (Figures 3B,C). Here, ESR2 is linked to melanoma.